興發集團(600141.SH):擬投建背壓式機組項目
格隆匯12月30日丨興發集團(600141.SH)公佈,公司九屆十八次董事會審議通過了關於公司孫公司內蒙古興發科技有限公司(“內蒙興發”)投資建設背壓式機組項目(“熱電聯產項目”)的議案。
投資概算37349萬元(含利用興瑞公司閒置資產8304萬元),項目計劃於2020年底前完工。
項目建成投產後,一是能夠為內蒙興發草甘膦生產提供穩定優質的蒸汽保障,充分釋放草甘膦產能,降低綜合生產成本,進一步提高內蒙興發經營效益;二是有利於完善內蒙興發戰略生產基地功能,為後續規劃項目提供配套用能保障,進一步增強內蒙興發可持續發展能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.